bioAffinity Technologies (BIAF) Competitors $0.21 +0.01 (+2.97%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$0.21 +0.00 (+0.14%) As of 05/16/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BIAF vs. HTCR, LUNA, STFS, ANTE, LIFW, ULY, ONMD, KRKR, GLXG, and SUGPShould you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include HeartCore Enterprises (HTCR), Luna Innovations (LUNA), Star Fashion Culture (STFS), AirNet Technology (ANTE), MSP Recovery (LIFW), Urgent.ly (ULY), OneMedNet (ONMD), 36Kr (KRKR), Galaxy Payroll Group (GLXG), and SU Group (SUGP). These companies are all part of the "business services" industry. bioAffinity Technologies vs. HeartCore Enterprises Luna Innovations Star Fashion Culture AirNet Technology MSP Recovery Urgent.ly OneMedNet 36Kr Galaxy Payroll Group SU Group bioAffinity Technologies (NASDAQ:BIAF) and HeartCore Enterprises (NASDAQ:HTCR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, community ranking, institutional ownership and valuation. Does the media prefer BIAF or HTCR? In the previous week, HeartCore Enterprises had 4 more articles in the media than bioAffinity Technologies. MarketBeat recorded 5 mentions for HeartCore Enterprises and 1 mentions for bioAffinity Technologies. bioAffinity Technologies' average media sentiment score of 1.44 beat HeartCore Enterprises' score of -0.30 indicating that bioAffinity Technologies is being referred to more favorably in the media. Company Overall Sentiment bioAffinity Technologies Positive HeartCore Enterprises Neutral Does the MarketBeat Community favor BIAF or HTCR? bioAffinity Technologies received 1 more outperform votes than HeartCore Enterprises when rated by MarketBeat users. Likewise, 50.00% of users gave bioAffinity Technologies an outperform vote while only 0.00% of users gave HeartCore Enterprises an outperform vote. CompanyUnderperformOutperformbioAffinity TechnologiesOutperform Votes150.00% Underperform Votes150.00% HeartCore EnterprisesOutperform VotesNo VotesUnderperform Votes1100.00% Which has stronger earnings & valuation, BIAF or HTCR? HeartCore Enterprises has higher revenue and earnings than bioAffinity Technologies. HeartCore Enterprises is trading at a lower price-to-earnings ratio than bioAffinity Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiobioAffinity Technologies$9.36M0.41-$7.94M-$0.77-0.27HeartCore Enterprises$30.41M0.39-$4.19M-$0.06-8.90 Which has more volatility and risk, BIAF or HTCR? bioAffinity Technologies has a beta of 3.01, indicating that its stock price is 201% more volatile than the S&P 500. Comparatively, HeartCore Enterprises has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500. Do institutionals and insiders hold more shares of BIAF or HTCR? 1.6% of bioAffinity Technologies shares are held by institutional investors. Comparatively, 1.7% of HeartCore Enterprises shares are held by institutional investors. 35.1% of bioAffinity Technologies shares are held by insiders. Comparatively, 64.2% of HeartCore Enterprises shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is BIAF or HTCR more profitable? HeartCore Enterprises has a net margin of 16.25% compared to bioAffinity Technologies' net margin of -91.22%. HeartCore Enterprises' return on equity of 65.33% beat bioAffinity Technologies' return on equity.Company Net Margins Return on Equity Return on Assets bioAffinity Technologies-91.22% -205.09% -115.95% HeartCore Enterprises 16.25%65.33%22.92% Do analysts prefer BIAF or HTCR? bioAffinity Technologies presently has a consensus price target of $6.00, indicating a potential upside of 2,734.20%. Given bioAffinity Technologies' stronger consensus rating and higher probable upside, equities analysts clearly believe bioAffinity Technologies is more favorable than HeartCore Enterprises.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00HeartCore Enterprises 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryHeartCore Enterprises beats bioAffinity Technologies on 10 of the 17 factors compared between the two stocks. Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIAF vs. The Competition Export to ExcelMetricbioAffinity TechnologiesCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.86M$2.94B$5.35B$8.51BDividend YieldN/A2.29%4.95%4.12%P/E Ratio-0.26103.7426.8919.99Price / Sales0.41164.72389.06119.28Price / CashN/A34.5738.2534.62Price / Book0.422.426.754.60Net Income-$7.94M$113.28M$3.23B$248.35M7 Day Performance2.77%1.51%4.86%5.12%1 Month Performance-58.89%1.25%9.90%13.65%1 Year Performance-90.63%-6.99%14.68%6.74% bioAffinity Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIAFbioAffinity Technologies2.7845 of 5 stars$0.21+3.0%$6.00+2,734.2%-91.4%$3.86M$9.36M-0.2610Positive NewsEarnings ReportHigh Trading VolumeHTCRHeartCore Enterprises2.5418 of 5 stars$0.64+3.9%N/A-35.3%$14.11M$30.41M2.6640News CoverageGap UpLUNALuna InnovationsN/A$0.40flatN/A-86.4%$13.58M$116.61M0.00390News CoverageGap DownSTFSStar Fashion CultureN/A$1.20-2.4%N/AN/A$13.02M$108.81M0.0022News CoveragePositive NewsGap DownANTEAirNet TechnologyN/A$0.90+4.8%N/A-29.3%$12.86M$343,000.000.0070News CoverageGap DownLIFWMSP RecoveryN/A$1.93+1.6%N/A-90.2%$12.67M$10.73M-0.013ULYUrgent.ly3.3343 of 5 stars$9.79-4.1%$12.00+22.6%-74.6%$12.19M$142.91M1.05753News CoveragePositive NewsEarnings ReportONMDOneMedNet0.9671 of 5 stars$0.38-6.3%N/A-13.8%$11.81M$643,000.00-1.072Earnings ReportKRKR36Kr0.6319 of 5 stars$5.80+2.8%N/A-21.3%$11.43M$231.07M-0.97570GLXGGalaxy Payroll GroupN/A$0.64+9.5%N/AN/A$11.32M$30.12M0.0026Gap UpSUGPSU Group1.5341 of 5 stars$0.80+4.0%N/A-65.2%$11.08M$182.16M0.00N/AGap Up Related Companies and Tools Related Companies HeartCore Enterprises Competitors Luna Innovations Competitors Star Fashion Culture Competitors AirNet Technology Competitors MSP Recovery Competitors Urgent.ly Competitors OneMedNet Competitors 36Kr Competitors Galaxy Payroll Group Competitors SU Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIAF) was last updated on 5/17/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
